NCT06461923 Home-based Gait Rehabilitation Service Using the Insole-type Gait Analysis Device for Children With Cerebral Palsy
| NCT ID | NCT06461923 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yonsei University |
| Condition | Gait Disorders, Neurologic |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2025-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2024-08-01 with a primary completion date of 2025-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Walking is a crucial daily activity that requires complex coordination of muscular systems. It is essential for bone and muscle health, cardiovascular fitness, and activities of daily living, making it an important indicator of prognosis and patient function. Insole gait analysis devices are affordable and easy to use, and they align well with standardized 3D gait analysis. However, their use outside of hospital settings is limited. This study aims to assess the usability and satisfaction of utilizing insole gait analysis devices for monitoring and providing feedback on the walking status of children with cerebral palsy exhibiting walking impairments in a home environment. Additionally, adherence to a home-based exercise program developed in this study will be evaluated.
Eligibility Criteria
Inclusion Criteria: 1. Patients diagnosed with cerebral palsy aged 7 to 18 years old 2. Patients classified as Gross Motor Function Classification System level 1 or 2 3. Individuals who visited Severance Hospital, comprehended the study, agreed to participate, and submitted the informed consent form Exclusion Criteria: 1. Individuals with complications such as severe foot deformities where the sensors of the insole gait analysis device cannot be recognized 2. In addition to above, individuals with clinically significant findings deemed inappropriate for this study by the study director or person in charge based on medical judgment
Contact & Investigator
Na Young Kim
PRINCIPAL INVESTIGATOR
Severance Hospital
Frequently Asked Questions
Who can join the NCT06461923 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 18 Years, studying Gait Disorders, Neurologic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06461923 currently recruiting?
Yes, NCT06461923 is actively recruiting participants. Contact the research team at GHDWNSXOR@yuhs.ac for enrollment information.
Where is the NCT06461923 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT06461923 clinical trial?
NCT06461923 is sponsored by Yonsei University. The principal investigator is Na Young Kim at Severance Hospital. The trial plans to enroll 10 participants.